Development of PD-1 and PD-L1 inhibitors as a form of cancer immunotherapy: a comprehensive review of registration trials and future considerations.

Saved in:
Bibliographic Details
Title: Development of PD-1 and PD-L1 inhibitors as a form of cancer immunotherapy: a comprehensive review of registration trials and future considerations.
Authors: Gong, Jun1 jgong@coh.org, Chehrazi-Raffle, Alexander2 Achehrazi-raffle@dhs.lacounty.gov, Reddi, Srikanth2 SReddi@dhs.lacounty.gov, Salgia, Ravi3 ajgong@coh.org
Source: Journal for ImmunoTherapy of Cancer. 1/23/2018, Vol. 6, p1-N.PAG. 18p.
Database: Academic Search Ultimate
Description
ISSN:20511426
DOI:10.1186/s40425-018-0316-z